Related Experiment Video
Updated: May 8, 2026

05:42
Quantitative PCR of T7 Bacteriophage from Biopanning
Published on: September 27, 2018
Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay
Francesca Bonvicini1, Elisabetta Manaresi, Gloria Bua
1Department of Pharmacy and Biotechnology.
Journal of Clinical Microbiology
|September 6, 2013
Summary
A new quantitative PCR (qPCR) assay effectively detects and differentiates all three parvovirus B19 genotypes (B19V). This assay offers improved diagnostic accuracy and epidemiological surveillance for B19V infections.
Area of Science:
- Virology
- Molecular Biology
- Infectious Diseases
Background:
- Parvovirus B19 (B19V) exhibits genetic diversity across three identified genotypes.
- This genetic variability poses challenges for developing accurate molecular detection assays.
- Existing assays may lack the ability to detect or differentiate all B19V genotypes.
Purpose of the Study:
- To examine B19V genetic variability using NCBI nucleotide database sequences.
- To establish a quantitative PCR (qPCR) assay capable of detecting, differentiating, and quantifying all B19V variants.
- To develop alternative detection formats utilizing intercalating dyes and genotype-specific probes.
Main Methods:
- Genomic sequence analysis from the NCBI nucleotide database.
- Design and validation of primers and probes for a novel qPCR assay.
- Performance evaluation using the 1st WHO International Reference Panel for Parvovirus B19 Genotypes.
- Comparison of the developed assay with a previously established B19V genotype 1-specific assay on clinical samples.
Main Results:
- The developed qPCR assay accurately detects B19V genotypes 1 to 3 with a limit of detection of 200 IU/ml.
- Analytical performance was confirmed using the WHO International Reference Panel.
- In routine testing of 130 clinical samples, the assay showed 96.92% agreement with a previous method, with 93.94% sensitivity and 97.94% specificity.
- Alternative detection formats were successfully developed.
Conclusions:
- The developed genotype-specific qPCR assay demonstrates robust performance for detecting and differentiating all B19V genotypes.
- Alternative detection protocols offer flexibility based on diagnostic needs.
- The assay and protocols can enhance diagnostic reliability and support B19V epidemiological surveillance.
